Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Else Nutrition Holdings ( (TSE:BABY) ) is now available.
Else Nutrition Holdings has surpassed one million cumulative cans sold across its toddler and kids powder product lines since launch, underscoring accelerating consumer demand in North America for clean, dairy-free, soy-free, gluten-free childhood nutrition products with no artificial additives. Management frames the milestone as evidence of growing parental trust and a strengthening community around the brand, citing thousands of testimonials about addressing gastrointestinal sensitivities, cow’s milk protein allergy, eczema, feeding issues, and other dietary restrictions. Alongside celebrating this sales threshold, the company is doubling down on its strategy in the pediatric nutrition market by reaffirming its commitment to advance regulatory efforts for U.S. approval of its plant-based infant formula under Operation Stock Speed, a move that could expand its addressable market and further entrench its position within the fast-growing plant-based nutrition category.
The most recent analyst rating on (TSE:BABY) stock is a Hold with a C$0.10 price target. To see the full list of analyst forecasts on Else Nutrition Holdings stock, see the TSE:BABY Stock Forecast page.
Spark’s Take on TSE:BABY Stock
According to Spark, TipRanks’ AI Analyst, TSE:BABY is a Neutral.
The score is weighed down primarily by weak financial performance (revenue contraction, negative gross profit, continued losses, negative equity, and ongoing cash burn). Technical indicators are only modestly supportive (some short-term improvement but a weaker longer-term trend), while valuation is not compelling given the negative P/E and no dividend yield.
To see Spark’s full report on TSE:BABY stock, click here.
More about Else Nutrition Holdings
Else Nutrition Holdings Inc. is a food and nutrition company in its international expansion stage, focused on developing innovative, clean, plant-based food and nutrition products for infants, toddlers, children, and adults. Its flagship offerings include a whole-food, plant-based, non-soy, non-dairy formula made from ingredients such as almonds, buckwheat, and tapioca, positioned as a clean-ingredient alternative to conventional dairy-based formulas. The company has built its presence through rapid sales growth, national retailer support, strong consumer reviews, and multiple industry awards recognizing its leadership in the plant-based and dairy-alternative segments.
Average Trading Volume: 99,577
Technical Sentiment Signal: Sell
Current Market Cap: C$3.74M
For an in-depth examination of BABY stock, go to TipRanks’ Overview page.